Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
| Low |
The actual benefit of the proprietary medicinal product NUCTALON is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. " |
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
aj2wnuASre5Su1n5
